Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Carcinoma of unknown primary (CUP), defined as metastatic cancers with unknown cancer origin, occurs in 3-5 per 100 cancer patients in the United States. Heterogeneity and metastasis of cancer brings great difficulties to the follow-up diagnosis and treatment for CUP. To find the tissue-of-origin (TOO) of the CUP, multiple methods have been raised. However, the accuracies for computed tomography (...
In recent years the concept of precision medicine has become a popular topic particularly in medical oncology. Besides the identification of new molec...
Exploring strategies to treat cancer has always been an aim of medical researchers. One of the available strategies is to use targeted therapy drugs t...
BACKGROUND: Sarcopenia has been confirmed as a poor prognostic indicator of lung cancer. However, the lack of abdominal computed tomography (CT) hinde...
Breast and ovarian cancers are the second and the fifth leading causes of cancer death among women. Predicting the overall survival of breast and ovar...
This study aimed to evaluate the role of magnetic liposome nanoparticles (ML NPs) as a carrier for paclitaxel (PTX) for the treatment of ovarian canc...
Breast cancer is one of the major public health issues and is considered a leading cause of cancer-related deaths among women worldwide. Its early dia...
BACKGROUND AND OBJECTIVE: Breast cancer is a frequently diagnosed cancer in women, contributing to significant mortality rates. Death rates are relati...
With the high prevalence of breast cancer, it is urgent to find out the intrinsic difference between various subtypes, so as to infer the underlying m...
BACKGROUND: To investigate the feasibility of a knowledge-based automated intensity-modulated radiation therapy (IMRT) planning technique for locally ...
BACKGROUND: As Crohn's disease (CD) is associated with a high risk of thromboembolic events (TE), including patients with subclinical inflammation, we...
BACKGROUND: Magnetic resonance images (MRI) is the main diagnostic tool for risk stratification and treatment decision in nasopharyngeal carcinoma (NP...
Research in medical imaging has yet to do to achieve precision oncology. Over the past 30 years, only the simplest imaging biomarkers (RECIST, SUV,…) ...
PURPOSE: Many researchers have developed deep learning models for predicting clinical dose distributions and Pareto optimal dose distributions. Models...
Cancer is a fatal illness often caused by genetic disorder aggregation and a variety of pathological changes. Cancerous cells are abnormal areas often...
The amount of "big" data generated in clinical oncology, whether from molecular, imaging, pharmacological, or biological origin, brings novel challeng...
Interstitial Ultrasound-guided High Intensity Focused Ultrasound (USgHIFU) therapy has the potential to deliver ablative treatments which conform to t...
Artificial intelligence (AI)-based models have become a growing area of interest in predictive medicine and have the potential to aid physician decisi...
Lung cancer remains the most common cause of cancer death worldwide. Recent advances in lung cancer screening, radiotherapy, surgical techniques, and ...